These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6822432)

  • 1. Serum resistance of Yersinia enterocolitica expressed in absence of other virulence markers.
    Chiesa C; Bottone EJ
    Infect Immun; 1983 Jan; 39(1):469-72. PubMed ID: 6822432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vwa+ phenotype of Yersinia enterocolitica.
    Perry RD; Brubaker RR
    Infect Immun; 1983 Apr; 40(1):166-71. PubMed ID: 6832830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination.
    Balligand G; Laroche Y; Cornelis G
    Infect Immun; 1985 Jun; 48(3):782-6. PubMed ID: 2987130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of virulence-associated autoagglutination to hemagglutinin production in Yersinia enterocolitica and Yersinia enterocolitica-like bacteria.
    Kapperud G; Lassen J
    Infect Immun; 1983 Oct; 42(1):163-9. PubMed ID: 6618663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the usefulness of selected virulence markers for the identification of virulent Yersinia enterocolitica strains. I. Phenotypic markders associated with Plasmid pYV].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):25-34. PubMed ID: 11107777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salt and acidic pH on the stability of virulence plasmid (pYV) in Yersinia enterocolitica and expression of virulence-associated characteristics.
    Bhaduri S
    Food Microbiol; 2011 Feb; 28(1):171-3. PubMed ID: 21056790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assessment of virulence in Yersinia enterocolitica and related species.
    Prpic JK; Robins-Browne RM; Davey RB
    J Clin Microbiol; 1985 Jul; 22(1):105-10. PubMed ID: 4019734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity of Yersinia enterocolitica serotype O3 biotype 3 strains.
    Kaneko S; Maruyama T
    J Clin Microbiol; 1987 Feb; 25(2):454-5. PubMed ID: 3818938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States.
    Kay BA; Wachsmuth K; Gemski P; Feeley JC; Quan TJ; Brenner DJ
    J Clin Microbiol; 1983 Jan; 17(1):128-38. PubMed ID: 6826697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum resistance associated with virulence in Yersinia enterocolitica.
    Pai CH; DeStephano L
    Infect Immun; 1982 Feb; 35(2):605-11. PubMed ID: 7056577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the usefulness of selected virulence markers for identification of virulent Yersinia enterocolitica strains. II. Genotypic markers associated with the pYV plasmid].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):35-49. PubMed ID: 11107778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of bacteriocin-like antagonism by clinical isolates of Yersinia enterocolitica.
    Cafferkey MT; McClean K; Drumm ME
    J Clin Microbiol; 1989 Apr; 27(4):677-80. PubMed ID: 2723036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of virulence markers in species of Yersinia isolated from animals in Nigeria.
    Adesiyun AA; Agbonlahor DE; Lombin LH; Kwaga JK
    Vet Microbiol; 1986 Sep; 12(3):289-94. PubMed ID: 3776097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence plasmid-associated autoagglutination in Yersinia spp.
    Skurnik M; Bölin I; Heikkinen H; Piha S; Wolf-Watz H
    J Bacteriol; 1984 Jun; 158(3):1033-6. PubMed ID: 6725209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid associated antibody production against Yersinia enterocolitica in man.
    Skurnik M; Nurmi T; Granfors K; Koskela M; Tiilikainen AS
    Scand J Infect Dis; 1983; 15(2):173-7. PubMed ID: 6879115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O:13a,13b, a new pathogenic serotype of Yersinia enterocolitica.
    Toma S; Wauters G; McClure HM; Morris GK; Weissfeld AS
    J Clin Microbiol; 1984 Nov; 20(5):843-5. PubMed ID: 6511868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions.
    Skurnik M
    Infect Immun; 1985 Jan; 47(1):183-90. PubMed ID: 3965395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of plasmid profile, exoenzyme activity, and virulence in recent human isolates of Yersinia enterocolitica.
    Bottone EJ; Janda JM; Chiesa C; Wallen JW; Traub L; Calhoun DH
    J Clin Microbiol; 1985 Sep; 22(3):449-51. PubMed ID: 4044802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors.
    Bengoechea JA; Najdenski H; Skurnik M
    Mol Microbiol; 2004 Apr; 52(2):451-69. PubMed ID: 15066033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between clinical and milk isolates of Yersinia enterocolitica.
    Butt HL; Gordon DL; Lee-Archer T; Moritz A; Merrell WH
    Pathology; 1991 Apr; 23(2):153-7. PubMed ID: 1745567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.